StonvexLoading…
StonvexStonvexStonvexCore line items from GEHC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $20.63B | $19.67B | $19.55B | $18.34B |
Operating Income | $2.76B | $2.63B | $2.44B | $2.52B |
Net Income | $2.08B | $1.99B | $1.57B | $1.92B |
EPS (Diluted) | $4.55 | $4.34 | $3.03 | $4.22 |
Total Assets | $36.91B | $33.09B | $32.45B | $27.54B |
Total Liabilities | $26.31B | $24.44B | $25.14B | $17.95B |
Cash & Equivalents | $4.49B | $2.87B | $2.49B | $1.44B |
Free Cash Flow OCF − CapEx | $1.50B | $1.55B | $1.71B | $1.82B |
Shares Outstanding | 458.00M | 459.00M | 455.34M | 100 |